NCT02453646View on ClinicalTrials.gov

Analysis of CRBSI Rates in Patients With a NexSite™ HD (Hemodialysis) Catheter

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 30, 2017

Study Completion Date

July 31, 2018

Conditions
End Stage Renal Disease
Interventions
DEVICE

NexSite HD Patients

Measurement of CRBSI rate and other device related adverse events in patients with NexSite HD Catheter.

Trial Locations (6)

27610

Capital Nephrology Associates, Raleigh

27834

Eastern Nephrology Associates, Greenville

28542

Eastern Nephology Associates, New Bern

29118

South Carolina Nephrology and Hypertension Center Inc, Orangeburg

78215

Renal Associates, San Antonio

79416

Lubbock Vascular Access Centre, Lubbock

Sponsors

Lead Sponsor

Marvao Medical
All Listed Sponsors
lead

Marvao Medical

INDUSTRY